27977 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 23
00:12 UTC
|
NAKA
KindlyMD
|
◎ Target | Fedor Shabalin ★★★☆☆ #974 | Buy | $11.00→ $13.00+18.2% |
|
Sep 23
00:12 UTC
|
MSTR
Strategy
|
◎ Target | Fedor Shabalin ★★★☆☆ #974 | Buy | $175.00→ $195.00+11.4% |
|
Sep 23
00:12 UTC
|
MSI
Motorola Solutions
|
◎ Target | James Fish ★★★☆☆ #1105 | Overweight | $530.00→ $531.00+0.2% |
|
Sep 23
00:12 UTC
|
MSFT
Microsoft
|
◎ Target | Brian Schwartz ★★★☆☆ #1505 | Outperform | $515.00→ $570.00+10.7% |
|
Sep 23
00:12 UTC
|
META
Meta Platforms
|
◎ Target | Brent Thill ★★☆☆☆ #2243 | Buy | $710.00→ $875.00+23.2% |
|
Sep 23
00:12 UTC
|
LEN
Lennar
|
◎ Target | Jade Rahmani ★★★☆☆ #980 | Underperform | $85.00→ $75.00-11.8% |
|
Sep 23
00:12 UTC
|
LAD
Lithia Motors
|
◎ Target | Michael Ward ★★★☆☆ #1878 | Buy | $455.00→ $409.00-10.1% |
|
Sep 23
00:12 UTC
|
KYMR
Kymera Therapeutics
|
◎ Target | Alex Thompson not yet tracked | Buy | $132.00→ $152.00+15.2% |
|
Sep 23
00:12 UTC
|
KMI
Kinder Morgan
|
◎ Target | Elvira Scotto ★★★☆☆ #2232 | Sec→ r Perform | $35.00→ $36.00+2.9% |
|
Sep 23
00:12 UTC
|
KBR
KBR
|
◎ Target | Ian Zaffino ★★★☆☆ #1264 | Outperform | $60.00→ $50.00-16.7% |
|
Sep 23
00:12 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Jessica Fye ★★★☆☆ #2160 | Overweight | $76.00→ $70.00-7.9% |
|
Sep 23
00:12 UTC
|
HWG
Harworth Group
|
◎ Target | firm only | Buy | GBX 202→ GBX 195-3.5% |
|
Sep 23
00:12 UTC
|
HWC
Hancock Whitney
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $87.00→ $86.00-1.1% |
|
Sep 23
00:12 UTC
|
HTFL
Heartflow
|
◎ Target | William Plovanic ★★★☆☆ #2029 | Buy | $45.00→ $56.00+24.4% |
|
Sep 23
00:12 UTC
|
HSDT
Solana
|
◎ Target | Fedor Shabalin ★★★☆☆ #974 | Buy | $3.50→ $4.00+14.3% |
|
Sep 23
00:12 UTC
|
HNGE
Hinge Health
|
◎ Target | Vikram Kesavabhotla ★★★☆☆ #983 | Neutral | $85.00→ $90.00+5.9% |
|
Sep 23
00:12 UTC
|
H
Hydro One
|
◎ Target | firm only | C$59.00→ C$56.00-5.1% | |
|
Sep 23
00:12 UTC
|
GRAL
GRAIL
|
◎ Target | Catherine Schulte not yet tracked | Outperform | $96.00→ $118.00+22.9% |
|
Sep 23
00:12 UTC
|
GKOS
Glaukos
|
◎ Target | Michael Sarcone ★★★☆☆ #2055 | Buy | $190.00→ $210.00+10.5% |
|
Sep 23
00:12 UTC
|
FWDI
Forward Industries
|
◎ Target | Fedor Shabalin ★★★☆☆ #974 | Buy | $9.00→ $11.00+22.2% |
|
Sep 23
00:12 UTC
|
FTS
Fortis
|
◎ Target | firm only | C$82.00→ C$78.00-4.9% | |
|
Sep 23
00:12 UTC
|
FICO
Fair Isaac
|
◎ Target | Jason Haas not yet tracked | Overweight | $1,450.00→ $1,350.00-6.9% |
|
Sep 23
00:12 UTC
|
FHN
First Horizon
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $28.50→ $28.00-1.8% |
|
Sep 23
00:12 UTC
|
EXC
Exelon
|
◎ Target | Marie Ferguson ★★★★☆ #655 | Buy | $52.00→ $49.00-5.8% |
|
Sep 23
00:12 UTC
|
EWBC
East West Bancorp
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $156.00→ $152.00-2.6% |
|
Sep 23
00:12 UTC
|
EMA
Emera
|
◎ Target | firm only | C$76.00→ C$72.00-5.3% | |
|
Sep 23
00:12 UTC
|
ELE
Elemental Royalty
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $33.00→ $31.00-6.1% |
|
Sep 23
00:12 UTC
|
ELD
Eldorado Gold
|
◎ Target | firm only | C$55.00→ C$63.00+14.5% | |
|
Sep 23
00:12 UTC
|
EFX
Equifax
|
◎ Target | Jason Haas not yet tracked | Overweight | $212.00→ $200.00-5.7% |
|
Sep 23
00:12 UTC
|
DHT.UN
DRI Healthcare Trust
|
◎ Target | firm only | Outperform | C$23.50→ C$25.50+8.5% |
|
Sep 23
00:12 UTC
|
DHI
D.R. Horton
|
◎ Target | Jade Rahmani ★★★☆☆ #980 | Market Perform | $167.00→ $160.00-4.2% |
|
Sep 23
00:12 UTC
|
DAVA
Endava
|
◎ Target | Nate Svensson ★★★★★ #144 | Hold | $3.00→ $2.00-33.3% |
|
Sep 23
00:12 UTC
|
DAR
Darling Ingredients
|
◎ Target | Manav Gupta ★★★★☆ #682 | Buy | $78.00→ $88.00+12.8% |
|
Sep 23
00:12 UTC
|
CU
Canadian Utilities
|
◎ Target | firm only | C$55.00→ C$52.00-5.5% | |
|
Sep 23
00:12 UTC
|
CSCO
Cisco Systems
|
◎ Target | James Fish ★★★☆☆ #1105 | Neutral | $132.00→ $125.00-5.3% |
|
Sep 23
00:12 UTC
|
CRH
CRH
|
◎ Target | Julian Radlinger ★★★★☆ #881 | Buy | $147.00→ $135.00-8.2% |
|
Sep 23
00:12 UTC
|
CPX
Capital Power
|
◎ Target | firm only | C$83.00→ C$80.00-3.6% | |
|
Sep 23
00:12 UTC
|
COLB
Columbia Banking System
|
◎ Target | Benjamin Gerlinger not yet tracked | Neutral | $32.00→ $31.00-3.1% |
|
Sep 23
00:12 UTC
|
CNTB
Connect Biopharma
|
◎ Target | Mazahir Alimohamed not yet tracked | Outperform | $5.00 |
|
Sep 23
00:12 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Joseph Pantginis ★★☆☆☆ #2265 | Buy | $42.00→ $64.00+52.4% |
|
Sep 23
00:12 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Kristen Kluska ★★★☆☆ #1463 | Overweight | $61.00→ $72.00+18.0% |
|
Sep 23
00:12 UTC
|
CHRD
Chord Energy
|
◎ Target | Josh Silverstein ★★☆☆☆ #2481 | Buy | $189.00→ $184.00-2.6% |
|
Sep 23
00:12 UTC
|
CCL
Carnival
|
◎ Target | Kevin Kopelman ★★★☆☆ #1814 | Buy | $34.00→ $32.00-5.9% |
|
Sep 23
00:12 UTC
|
BPOP
Popular
|
◎ Target | Benjamin Gerlinger not yet tracked | Buy | $200.00→ $192.00-4.0% |
|
Sep 23
00:12 UTC
|
BOOT
Henry Boot
|
◎ Target | firm only | Buy | GBX 219→ GBX 186-15.1% |
|
Sep 23
00:12 UTC
|
BMNR
BitMine Immersion Technologies
|
◎ Target | Fedor Shabalin ★★★☆☆ #974 | Buy | $30.00→ $34.00+13.3% |
|
Sep 23
00:12 UTC
|
AXS
Accsys Technologies
|
◎ Target | firm only | Buy | GBX 130→ GBX 120-7.7% |
|
Sep 23
00:12 UTC
|
ASST
Strive
|
◎ Target | Fedor Shabalin ★★★☆☆ #974 | Buy | $26.00→ $33.00+26.9% |
|
Sep 23
00:12 UTC
|
AQN
Algonquin Power & Utilities
|
◎ Target | firm only | C$6.25→ C$6.00-4.0% | |
|
Sep 23
00:12 UTC
|
APH
Amphenol
|
◎ Target | Andrew Buscaglia ★★☆☆☆ #2700 | Outperform | $107.50→ $110.00+2.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.